Level Bio AB (NGM:LEVBIO) Total Liabilities: kr12.65 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LEVBIO Level Bio AB NGM:LEVBIO
22 GF Score
Price kr0.38
! 4 Warning Signs
View Full Analysis

What is Level Bio AB Total Liabilities?

Level Bio AB NGM:LEVBIO +31.94% 22 Total Liabilities is kr12.65 Mil as of Mar. 2026. GuruFocus rates NGM:LEVBIO with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Level Bio AB's Total Liabilities for the quarter that ended in Mar. 2026 was kr12.65 Mil.

Level Bio AB's quarterly Total Liabilities increased from Sep. 2025 (kr11.51 Mil) to Dec. 2025 (kr13.41 Mil) but then declined from Dec. 2025 (kr13.41 Mil) to Mar. 2026 (kr12.65 Mil).

Level Bio AB's annual Total Liabilities increased from Dec. 2023 (kr8.68 Mil) to Dec. 2024 (kr11.20 Mil) and increased from Dec. 2024 (kr11.20 Mil) to Dec. 2025 (kr13.41 Mil).

Level Bio AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Level Bio AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB Total Liabilities Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.95 8.91 8.68 11.20 13.41

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.20 11.30 11.51 13.41 12.65
NGM:LEVBIO
22GF Score
Level Bio AB NGM:LEVBIO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Level Bio AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12.964+(0.338+0.112
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=13.41

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=14.051-0.637
=13.41

Level Bio AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12.327+(0+0.325
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=12.65

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=13.12-0.468
=12.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr12.65 Mil mean?
Level Bio AB (NGM:LEVBIO) has a Total Liabilities of kr12.65 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Level Bio AB and its competitors.
Is Level Bio AB's Total Liabilities too high?
Level Bio AB's current Total Liabilities is kr12.65 Mil. Overall, Level Bio AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Total Liabilities compare to TMO and DHR?
Level Bio AB's Total Liabilities of kr12.65 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Level Bio AB and its competitors. Level Bio AB's current Total Liabilities is kr12.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (NGM:LEVBIO) has a current Total Liabilities of kr12.65 Mil. The current Total Liabilities is kr12.65 Mil. Level Bio AB's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Level Bio AB (NGM:LEVBIO), the current Total Liabilities is kr12.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
22GF Score

Get the complete analysis for NGM:LEVBIO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.38
Price